---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-053305"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T08:22:09.552266+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elanco appoints Robert VanHimbergen as CFO effective July 7, 2025

## Summary
- Robert VanHimbergen appointed EVP and CFO, effective July 7, 2025; Todd Young stays as advisor through Aug 31, 2025.
- VanHimbergen previously SVP and CFO of Hillenbrand; prior 15 years at Johnson Controls and PwC.
- Base salary $660k, target annual cash incentive 75% of base, annual long-term incentive target $2.645M.
- Make-whole awards: cash bonus $890k (3-year clawback) and RSU $1.735M (3-year ratable vesting).
- Company reaffirmed Q2 and FY 2025 guidance issued May 7, 2025.

## SEC filing metadata
- accession: 0001104659-25-053305
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/0001104659-25-053305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/tm2516292d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-053305
- JSON: https://secwatch.observer/filing/0001104659-25-053305.json
- Plain text: https://secwatch.observer/filing/0001104659-25-053305.txt

## Key facts
- Executive change
  Robert VanHimbergen was appointed as Executive Vice President and Chief Financial Officer at Elanco Animal Health Inc.
  - Action: appointed
  - Role: Executive Vice President and Chief Financial Officer
  source text: the Company announced the appointment of Robert (Bob) VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/0001104659-25-053305-index.htm
- Executive change
  Todd Young changed role as Chief Financial Officer at Elanco Animal Health Inc.
  - Action: succeeded
  - Role: Chief Financial Officer
  source text: Mr. VanHimbergen succeeds Todd Young who will continue to serve as an advisor, in a non-executive capacity, through August 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/0001104659-25-053305-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.